Lifeward Ltd. (LFWD)
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN 
Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates
Lifeward (LFWD) came out with a quarterly loss of $1.46 per share versus the Zacks Consensus Estimate of a loss of $1.49. This compares to a loss of $6.96 per share a year ago.
Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript
Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Lifeward (LFWD) came out with a quarterly loss of $6.7 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $5.52 per share a year ago.
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript
Lifeward Ltd. (LFWD) Q3 2025 Earnings Call Transcript
Lifeward Ltd. ( LFWD ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Almog Adar - Chief Financial Officer William Grant - President, CEO & Director Conference Call Participants Yale Jen - Laidlaw & Company (UK) Ltd.
Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript
Lifeward Ltd. (NASDAQ:LFWD ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Almog Adar - Chief Financial Officer William Mark Grant - President, CEO & Director Conference Call Participants Benjamin Charles Haynor - Lake Street Capital Markets, LLC, Research Division I-Eh Jen - Laidlaw & Company (UK) Ltd.
Lifeward (LFWD) Reports Q2 Loss, Lags Revenue Estimates
Lifeward (LFWD) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.5 per share a year ago.
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Lifeward (LFWD) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.73 per share a year ago.
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7
Lifeward launches ReWalk 7 in the United States, offering advanced mobility, greater control and smarter walking for individuals with spinal cord injuries.
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton
LFWD secures FDA clearance for its ReWalk 7 Exoskeleton, introducing enhanced features to empower individuals with spinal cord injury and expand mobility options.
Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript
Lifeward Ltd. (NASDAQ:LFWD ) Q4 2024 Earnings Conference Call March 7, 2025 8:30 AM ET Company Participants Mike Lawless - CFO Larry Jasinski - CEO Almog Adar - VP, Finance Conference Call Participants Yale Jen - Laidlaw & Company Ben Haynor - Lake Street Capital Markets Swayampakula Ramakanth - H.C.
Lifeward (LFWD) Reports Q4 Loss, Tops Revenue Estimates
Lifeward (LFWD) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.35 per share a year ago.
